BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Shares Outstanding (2015 - 2026)

BeyondSpring (BYSI) posted Shares Outstanding (Entity) of $41.1 million for Q1 2026, little changed sequentially from $41.1 million in Q4 2025, and up 1.99% YoY from $40.3 million in Q1 2025.

BeyondSpring (BYSI) Shares Outstanding (2015 - 2026) Analysis & Trends

BeyondSpring has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $41.1 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 1.99% year-over-year to $41.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.1 million (up 1.99% YoY) and the FY2025 annual result came in at $41.1 million, up 2.0% from the prior year.
  • Shares Outstanding (Entity) was little changed at $41.1 million in Q1 2026 per BYSI's latest filing, from $41.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $41.1 million in Q4 2025 and troughed at $39.0 million in Q2 2022.
  • A 5-year average of $39.9 million and a median of $40.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) fell 0.41% in 2022, then advanced 3.3% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $39.0 million in 2022, then climbed by 0.08% to $39.0 million in 2023, then increased by 3.3% to $40.3 million in 2024, then gained by 2.0% to $41.1 million in 2025, then slipped by 0.01% to $41.1 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $41.1 million, $41.1 million, and $40.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 BeyondSpring 29.85 Mn 29.85 Mn - 41.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 41.12 Mn
Mar 31, 2026 41.12 Mn
Dec 31, 2025 40.41 Mn
Sep 30, 2025 40.32 Mn
Jun 30, 2025 40.32 Mn
Mar 31, 2025 40.32 Mn
Dec 31, 2024 39.73 Mn
Sep 30, 2024 40.30 Mn
Jun 30, 2024 39.28 Mn
Mar 31, 2024 39.03 Mn
Dec 31, 2023 39.00 Mn
Jun 30, 2023 38.98 Mn
Dec 31, 2022 39.09 Mn
Jun 30, 2022 39.07 Mn
Dec 31, 2021 39.02 Mn
Sep 30, 2021 39.02 Mn
Jun 30, 2021 39.01 Mn
Mar 31, 2021 39.00 Mn
Dec 31, 2020 29.98 Mn
Sep 30, 2020 30.30 Mn